Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
660-01-010 ISMRM Abstract

Abdominal Multi-Organ MRI Radiomics Outperform Standard Approaches for Predicting Outcomes in pancreatic cancer

Primary: Body - Pancreas
Secondary: Analysis Methods - Radiomics
660-01-010 · A Tour of Body Oncology · Thursday, 14 May, 8:30 AM–9:25 AM · Digital Posters Row A
Keywords: Survival risk stratification Pancreatic ductal adenocarcinoma Radiomics analysis Magnetic resonance imaging Dynamic enhancement Liver metastases
Accepted
Lixia A Wang 1, Yufeng Wang1, Zengtian Deng1,2, Yu Shi1,2, Touseef A Qureshi1, Sehrish Javed1, Linda Azab1, Garima Diwan1, Ju D Yang3, Yibin Xie1, Arsen Osipov4, Stephen J Pandol5, Debiao Li1,6
1Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, United States of America
2UCLA, Los Angeles, California, United States of America
3Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, United States of America
4Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, United States of America
5Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, United States of America
6Department of Bioengineering, University of California Los Angeles, Los Angeles, United States of America
Presenting Author: Lixia A Wang

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. Ca 75, 10 (2025), doi: 10.3322/caac.21871. [doi]
2. Osipov, A. et al. The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients. Nature Cancer 5, 299-314, doi:10.1038/s43018-023-00697-7 (2024). [doi]
3. Perrotta, G. et al. CLINICAL STAGING OF STAGE I PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS UNRELIABLE, ACCURATE IN ONLY ABOUT 25% - RESULTS FROM A LARGE NATIONAL COHORT. Gastrointestinal Endoscopy 99, AB872, doi:10.1016/j.gie.2024.04.2057 (2024). [doi]
4. Tong, J. et al. Risk Factors of Early Liver Metastasis for Pancreatic Ductal Adenocarcinoma after Radical Resection. Gastroenterol Res Pract 2022, 8061879, doi:10.1155/2022/8061879 (2022). [doi]
5. Zhao, B. et al. Development of a radiomics-based model to predict occult liver metastases of pancreatic ductal adenocarcinoma: a multicenter study. Int J Surg 110, 740-749, doi:10.1097/js9.0000000000000908 (2024). [doi]
6. Gebauer, L. et al. Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer. Cancers (Basel) 13, doi:10.3390/cancers13225732 (2021). [doi]
7. Huang, Y. et al. Development and validation of a radiomics model of magnetic resonance for predicting liver metastasis in resectable pancreatic ductal adenocarcinoma patients. Radiat Oncol 18, 79, doi:10.1186/s13014-023-02273-w (2023). [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/660-01-010